![]() |
|
|
Vol. 20, Issue 20, 4435-4443, October 15, 2009
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Cell Science, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan
Submitted March 25, 2009;
Revised July 20, 2009;
Accepted August 19, 2009
Monitoring Editor: Jean E. Gruenberg
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
When phagosomes take up large particles, the phagosome membranes are thought to be supplied not only from invaginated plasma membrane but also from the membranes of intracellular organelles (Desjardins, 2003
), including early endosomes or recycling endosomes. Exocytosis at the site of phagosome formation in these organelles is mediated by a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein, VAMP3 (also called cellubrevin; Bajno et al., 2000
; Coppolino et al., 2001
). Another intracellular source of membrane is late endosomes, which are exocytosed by a VAMP7 (also called TI-VAMP)-related fusion process during Fc receptor–mediated phagocytosis (Braun et al., 2004
). However, in dendritic cells, VAMP7 as well as VAMP8 (also called endobrevin) are negative regulators of phagocytosis (Ho et al., 2008
). Also, in recent studies on the ingestion of large particles (3.0–6.0 µm) by macrophages, the recruitment of the peripheral domains of lysosomes to nascent phagosomes and the mobilization of recycling endosomes as a source of endomembrane during phagocytosis occurred in a synaptotagmin VII–dependent (Czibener et al., 2006
) and a synaptotagmin V–dependent (Vinet et al., 2008
) manner, respectively.
In addition to organelles related to the endosome/lysosome pathway, the endoplasmic reticulum (ER) has also been implicated in phagosome formation. ER-derived membrane has been observed in the bottom of forming phagosomes, and some ER-resident proteins were detected in a proteomics analysis of isolated phagosomes (Gagnon et al., 2002
; Desjardins, 2003
). Also, all constituents of the major histocompatibility complex (MHC) class I processing and presentation machinery, which are ER-resident proteins, have been found in phagosomes (Ackerman et al., 2003
; Guermonprez et al., 2003
; Houde et al., 2003
), indicating that the cross-presentation of foreign antigens could be initiated in phagosomes. Despite these findings, the existence of ER-mediated phagocytosis per se remains highly controversial (Groothuis and Neefjes, 2005
; Touret et al., 2005
).
Fusion between the vesicle and the target membrane is mediated by SNARE proteins extended from each membrane. The SNARE complex produces a parallel four-helix bundle, of which three helices are extended from one membrane by proteins of the syntaxin and synaptosomal associated protein of 25 kDa (SNAP-25) families (Q-SNAREs) that contain a conserved glutamine residue at a central position called the "0" layer, and one helix is extended from the opposite membrane by a protein of the VAMP or synaptobrevin family (an R-SNARE) that contains a conserved arginine residue at the same position (Fasshauer et al., 1998
; Jahn et al., 2003
; Jahn and Scheller, 2006
). In the ER, syntaxin 18, D12 (also called p31), and BNIP1 are Q-SNARE proteins, and Sec22b (also called ERS-24) is classified as an R-SNARE (Hatsuzawa et al., 2000
; Nakajima et al., 2004
; Jahn and Scheller, 2006
; Okumura et al., 2006
). Recently, we have shown that syntaxin 18 is involved in membrane fusion between the ER and the plasma membrane during phagocytosis in macrophages (Hatsuzawa et al., 2006
). We found the ER-localized SNARE proteins syntaxin 18, D12, and Sec22b in phagosomes from the earliest stage of phagosome formation. Interestingly, Becker et al. (2005)
observed that introduction of a dominant-negative form (cytoplasmic region) of Sec22b or anti-Sec22b antibodies into macrophages selectively inhibited phagocytosis of relatively large 3-µm latex beads. These observations support the involvement of the ER in phagocytosis by macrophages. However, the molecular mechanism by which the ER-localized SNARE proteins regulate phagocytosis is not clear. Here, we show that Sec22b plays an inhibitory role in phagocytosis through an interaction with syntaxin 18 and/or D12 in J774 macrophages.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
J774 cells were obtained from the Riken Cell Bank (Tsukuba, Japan) and grown in RPMI 1640 medium (Wako Pure Chemical Industries, Osaka, Japan) supplemented with 10% fetal calf serum (FCS). J774 cells stably expressing mVenus-tagged proteins were maintained in RPMI 1640 with 10% FCS containing puromycin (final concentration 2 µM). 293T cells were cultured in DMEM-high glucose (Sigma-Aldrich) supplemented with 10% FCS. All cell lines were cultured at 37°C under 5% CO2.
Expression Vectors and Establishment of Stable Transformants
The expression plasmids for syntaxin 18, D12, and Sec22b were constructed by subcloning cDNA fragments by PCR into pmVenus-C1 vector as described previously (Hatsuzawa et al., 2006
). The J774 cell lines expressing mVenus-tagged proteins [J774/mVenus, J774/mVenus-syntaxin 18, J774/mVenus-D12, J774/mVenus-Sec22b (1-215), J774/mVenus-Sec22b
TMD (1-195), and J774/mVenus-R-SNARE (100-195)] were established by infection with recombinant retroviruses generated using cDNAs of mVenus-tagged proteins cloned into the pCX4puro vector as described (Akagi et al., 2003
; Hatsuzawa et al., 2006
).
Opsonized Fluorescein Isothiocyanate–conjugated Zymosan Assay
J774 cells stably expressing mVenus-tagged proteins were plated at a density of 0.75 x 106 cells per well in a 24-well dish and cultured overnight. The culture medium was exchanged with fresh medium, and 30 min later the cells were incubated for 1 h in the presence or absence of 2.25 x 107 fluorescein isothiocyanate (FITC)-conjugated zymosan A particles (Cat. no. Z2841; Molecular Probes) which had been treated with opsonizing reagent (rabbit anti-zymosan IgG, Cat. no. Z2850; Molecular Probes). The cells were then washed extensively with ice-cold PBS to remove free particles. Trypan blue solution (0.25 mg/ml in 20 mM sodium citrate, pH 4.4, containing 150 mM NaCl) was then added to quench the fluorescence of noninternalized particles. After 3 min the solution was removed, and fluorescence was quantitatively measured in a Plate Chameleon V microplate reader (Hidex, Turku, Finland) using 485 nm for excitation and 535 nm for emission. Arbitrary fluorescence units were obtained by subtracting the fluorescence intensity observed in the absence of IgG-opsonized FITC-conjugated zymosan particles from that observed in the presence of the particles and normalized to the maximal value obtained for J774/mVenus cells within the same experiment, which was set to 100%. Alternatively, cells were incubated for 30 min on ice with IgG-opsonized FITC-conjugated zymosan particles in the presence of cytochalasin B (final concentration 10 µM) and then washed thoroughly with ice-cold PBS to remove free particles. The fluorescence of the particles associated with the cells was then measured as described above.
Small Interfering RNA Experiment
The RNA duplex used for targeting was mouse Sec22b siRNA (5'-GCCGUGCUCGGAGAAAUCUAG-3'; RNAi Co., Tokyo, Japan). A small interfering RNA (siRNA) duplex containing 47% GC content (Cat. no. D-001206-09-05; Dharmacon, Lafayette, CO) was used as a control. J774 cells were transfected with either control or Sec22b siRNA using Lipofectamine (Invitrogen, Tokyo, Japan). Twenty-four hours after transfection, the siRNAs were transfected into the cells again under the same conditions. Forty-eight hours after the first transfection, the cells were split into two dishes for Western blot analysis and an opsonized FITC-conjugated zymosan assay.
Immunoprecipitations
Cell lysates were prepared from either J774 cells stably expressing monomeric Venus (mVenus)-tagged proteins or 293T cells transiently cotransfected with mVenus-tagged proteins and Myc-tagged syntaxin 18 constructs as described (Hatsuzawa et al., 2006
). The lysates were incubated with an anti-EGFP antibody for 30 min at 4°C. protein A-Sepharose (GE Healthcare Bio-Sciences., Tokyo, Japan) was then added, and the mixture was allowed to incubate for 16 h at 4°C with gentle rotation. The beads were washed four times with extraction buffer (20 mM HEPES-KOH, pH 7.2, 100 mM KCl, 2 mM EDTA, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, and a protease inhibitor cocktail; Nakarai Chemicals, Kyoto, Japan). The immune-complexes were eluted from the Sepharose beads with SDS-PAGE sample buffer. In addition, 10% of the total lysate volume was mixed with 5x SDS-PAGE sample buffer and heated at 95°C for 5 min. After SDS-PAGE, the samples were analyzed by Western blotting using ReliaBLOT (Bethyl Laboratories, Montgomery, TX) according to the manufacturer's instructions. Immunoreactive proteins were visualized using ECL Western Blotting Detection Reagents (GE Healthcare Bio-Sciences).
Proteinase K Digestion
J774 cells stably expressing mVenus-Sec22b
TMD and 293T cells transiently transfected with an mVenus-Sec22b
TMD construct were homogenized by fifteen passages through a 25-gauge needle in ice-cold homogenization buffer (20 mM HEPES-KOH, pH 7.2, 0.25 M sucrose, and a protease inhibitor cocktail; Nakarai Chemicals). The homogenates were centrifuged at 2500 rpm for 10 min at 4°C in a microcentrifuge to remove nuclei and unbroken cells. An aliquot of the postnuclear supernatant was incubated with proteinase K (ProK) at a final concentration of 5, 10, 20, 25, or 50 µg/ml for 15 min on ice. The reaction was stopped by adding phenylmethylsulfonyl fluoride (final concentration 5 mM). The samples were mixed with 5x SDS-PAGE sample buffer and heated at 95°C for 5 min. After SDS-PAGE, the samples were analyzed by Western blotting using an anti-Sec22b antibody.
Immunofluorescence
Immunofluorescence microscopy was performed as described previously (Hatsuzawa et al., 2006
). Briefly, J774 cells expressing mVenus-tagged proteins were fixed with 4% paraformaldehyde for 15 min on ice. The cells were then incubated with goat polyclonal anti-CD64 diluted 1:50, followed by incubation with secondary antibody conjugated to Alexa594 (Molecular Probes) diluted 1:200. Confocal microscopy was performed on an LSM510meta laser scanning microscope using a plan-Apochromat 63x NA 1.4 oil immersion objective (Zeiss, Oberkochen, Germany).
Statistics
Data are presented as mean ± SE for the number of experiments indicated in the figure legends. Statistical significance was determined with Student's pared t test (one-tailed) using GraphPad Prism (GraphPad Software, San Diego, CA). Differences between the analyzed samples were considered significant at p < 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
to the cell surface at the site of phagocytic cup formation in activated macrophages (Murray et al., 2005To investigate which stage of phagocytosis is impaired by Sec22b overexpression, we measured the kinetics of phagocytosis using IgG-opsonized FITC-zymosan particles. As shown in Figure 2C, J774/mV-22b cells showed a markedly reduced rate of particle uptake compared with J774/mV cells as early as 5 min of incubation and reached a near plateau at 30 min, indicating that the J774/mV-22b cells are impaired in membrane fusion, most likely between the ER and the plasma membrane. This data suggests that overexpression of Sec22b inhibits an early step in phagocytosis rather than phagosome maturation.
Knockdown of Sec22b Expression Augments Phagocytosis Activity in J774 Macrophages
To test whether the observed suppression of phagocytosis in J774/mV-22b cells was the result of augmented Sec22b function, we examined the effects of a siRNA against Sec22b. Transfection of the cells with Sec22b siRNA decreased Sec22b expression to
50% of the control value (Figure 3A andFigure 3B). A slight decrease was also observed for endogenous proteins such as CD64, syntaxin 4, and syntaxin 18 (Figure 3, A and B). The opsonized FITC-zymosan assay showed a significant increase in phagocytosis activity in the Sec22b siRNA cells to
130% of control (Figure 3D), although the siRNA treatment had no effect on the association of zymosan particles with the cells (Figure 3C). Likewise, Sec22b siRNA enhanced phagocytosis activity using the luminol bead assay (Supplementary Figure S2). These findings strongly suggest that the inhibition of phagocytosis as shown in Figures 1 and 2 is due to a dominant-active effect of the expressed mV-22b rather than a dominant-negative one, thus implying that endogenous Sec22b negatively regulates phagocytosis in J774 cells.
|
TMD) or the R-SNARE motif (100-195) of Sec22b (mV-22b-R-SNARE) N-terminally fused to mVenus had a dominant-negative effect on phagocytosis in J774 cells. To this end, we generated J774 cells stably expressing each mutant (Figure 4B). Immunofluorescence analysis showed that mV-, mV-22b
TMD-, and mV-22b-R-SNARE were distributed throughout the cytoplasm (Figure 4B), whereas mV-22b was largely confined to the ER. Overexpression of these proteins had no effect on the expression of endogenous plasmalemmal proteins such as CD64 (Supplementary Figure S3) and had no effect on the association of opsonized zymosan particles with the cells (Figure 4C). Unexpectedly, when the opsonized FITC-zymosan assay was performed with the mutant cells, a potent inhibition of phagocytosis was observed in the J774/mV-22b-R-SNARE cells (Figure 4D), suggesting that the inhibitory effects of mV-22b on phagocytosis are mediated through the R-SNARE motif. Interestingly, J774/mV-22b
TMD cells exhibited an apparent augmentation of phagocytosis activity compared with J774/mV control cells, despite the presence of the R-SNARE motif (Figure 4D). However, this result seemingly contradicts our previous data from the same J774/mV-22b
TMD cells using the luminol bead assay (see supplementary Figure S1C of our previous report; Hatsuzawa et al., 2006
TMD cells. As shown in Supplementary Figure S4, ROS generation by phorbol 12-myristate 13-acetate (PMA) stimulation was strongly reduced in the J774/mV-22b
TMD cells compared with the J774/mV cells. Therefore, our previous inhibitory data observed in the J774/mV-22b
TMD cells was due to a defect in ROS generation ability rather than phagocytosis activity.
|
TMD compared with mV-Sec22b wild type or mV-22b-R-SNARE (Figure 5A). These results mirror the profile of phagocytosis activity shown in Figure 4D. The low level of interaction with syntaxin 18 and/or D12 observed in J774/mV-22b
TMD cells suggests that the R-SNARE motif of mV-22b
TMD is masked by its N-terminal, profilin-like, longin domain and takes a closed conformation, similar to that of Ykt6 (Fukasawa et al., 2004
|
TMD (Figure 4D), it has been previously reported that transient introduction of GST-tagged Sec22b
TMD into J774 cells decreased the efficiency of phagocytosis (Becker et al., 2005
TMDs and syntaxin 18. To confirm this, we transiently coexpressed mVenus-Sec22b mutants with Myc-syntaxin 18 (Myc-syx18) and then incubated the lysates from these cells with anti-EGFP antibodies. Immunoprecipitates were analyzed by Western blotting with anti-Myc and anti-EGFP antibodies (Figure 5B). In contrast to the results in Figure 5A, all Sec22b mutants including mV-22b
TMD interacted with Myc-syx18 efficiently (Figure 5B, top panel). However, because overexpression of full-length syntaxin 18 tends to cause aggregation of the ER membranes (Hatsuzawa et al., 2000
TMD may have been nonspecifically trapped in the aggregates. To exclude this possibility, we performed the same immunoprecipitation experiment using Myc-syntaxin 18
TMD (Myc-syx18
TMD) whose overexpression does not cause aberrant changes in the apparent ER structure (Hatsuzawa et al., 2000
TMD, unlike mV-22b
TMD in the stable transformant, may form an open conformation to allow the R-SNARE motif to interact with syntaxin 18, resulting in negative regulation of phagocytosis (Becker et al., 2005
TMD, postnuclear supernatants from J774/mV-22b
TMD cells (stably expressed) and 293T/mV-22b
TMD cells (transiently expressed) were subjected to ProK digestion (Figure 5C). Quantification of the full-length band ("mV-22b
TMD") revealed that indeed transiently expressed mV-22b
TMD was more sensitive to ProK digestion than the stably expressed mV-22b
TMD (Figure 5D). Endogenous Sec22b, in both stably (J774) and transiently expressing (293T) cells, showed similar resistance to ProK digestion (Figure 5D). Of note, is a fragment of
30-kDa, which was detected in the stably expressed J774/mV-22b
TMD cells (Figure 5C). These data indicate that the stably expressed mV-22b
TMD in J774 cells forms a more compact conformation than the transiently expressed mV-22b
TMD and that presumably the former would represent a closed conformation and the latter an open one.
These data indicate that Sec22b interacts with other ER-localized SNARE proteins through its R-SNARE motif and that these interactions may reduce the fusion-competent pools of syntaxin 18 and D12, which are necessary for ER-mediated phagocytosis (Hatsuzawa et al., 2006
). Taken together, our results strongly suggest that Sec22b is a negative regulator of phagocytosis in macrophages.
| DISCUSSION |
|---|
|
|
|---|
Overexpression of a truncated SNARE protein lacking the TMD (
TMD) often inhibits specific membrane fusion. For example, overexpression of syntaxin 18
TMD or D12
TMD inhibited phagocytosis (Hatsuzawa et al., 2006
), whereas overexpression of their full-length forms enhanced the efficiency of phagocytosis (Figure 1C and Supplementary Figure S1). In this context, Becker et al., (2005)
reported that the introduction of GST-tagged Sec22b
TMD and/or an anti-Sec22b Fab fragment into J774 cells inhibited phagocytosis of IgG-opsonized 3.0-µm beads. The authors concluded that a functional Sec22b is required for membrane fusion between the ER and the plasma membrane during Fc-receptor-mediated phagocytosis (Becker et al., 2005
). However, this conclusion contradicts our observation that J774 cells overexpressing mVenus-tagged full-length Sec22b, unlike cells expressing syntaxin 18 or D12, were deficient in phagocytosis (Figure 1C and Supplementary Figure S1). Furthermore, the siRNA-mediated suppression of Sec22b enhanced phagocytosis activity (Figure 3D and Supplementary Figure S2). One possible explanation for the difference in the effect on phagocytosis between our siRNA data and Becker et al.'s data using an anti-Sec22b Fab fragment is that the introduced Fab fragment could enhance the assembly of the SNARE complex through interrupting the entry of NSF/
-SNAP by its binding to Sec22b, resulting in depletion of a pool of free syntaxin 18 and/or D12. If this occurs, reduction of free syntaxin 18 and/or D12 would cause phagocytosis inhibition. In contrast, knockdown of Sec22b by siRNA could increase the pool of free syntaxin 18 and/or D12, thereby enhancing phagocytosis activity. Alternatively, steric hindrance of the Fab fragment bound to Sec22b might have caused indirect effects, or it is even possible that the reductive environment of the cytoplasm may have denatured the Fab fragment and unrelated effects were exerted.
Hence, we postulate that Sec22b functions as a negative regulator of phagocytosis, a function that is consistent with the general idea of inhibitory SNAREs (i-SNAREs), which form nonfusogenic SNARE complexes that have an important role in fine tuning the specificity of fusion (Varlamov et al., 2004
). Considering the results of our coimmunoprecipitation experiments with syntaxin 18 or D12 and Sec22b mutants (Figure 5, A and B), we propose that Sec22b specifically sequesters these ER-localized free SNARE proteins, thereby preventing excessive membrane fusion at the site of phagocytosis (Figure 6). This model predicts that activation signal of phagocytosis triggers formation of the closed conformation of Sec22b, thereby increasing the pool of free SNARE proteins such as syntaxin 18 and/or D12, probably through stimulation of the acceptor complex disassembly (Figure 6). In this context, stably expressed mV-22b
TMD might represent the "closed," physiologically active form for phagocytosis. The closed conformation is thought to be formed when the R-SNARE motif of Sec22b binds back onto its N-terminal longin domain under certain conditions without interacting with other SNARE partners (Mancias and Goldberg, 2007
). Only the stably expressed mV-22b
TMD would be in a closed rather than open conformation (Figure 5A), whereas the transiently expressed mV-22b
TMD would be in an open conformation (Figure 5B). The results of ProK treatment (Figure 5, C and D) are consistent with the presence of a compact form in stably expressed mV-22bTMD. The precise reason for this is currently unclear. Although it is possible that formation of the proper "closed conformation" may be a slow process, we think it more likely that the open form is actively converted to the closed one by some unknown machinery and that the function is up-regulated in the J774 cells stably expressing mV-22b
TMD. This hypothesis would explain why phagocytosis occurs more efficiently in the J774/mV-22b
TMD cells. When phagocytosis signal is emanated, the up-regulated conversion machinery would cause an efficient disassembly of the acceptor complex, and then the released syntaxin 18 and D12 would stimulate phagocytosis. We do not exclude the possibility that there may be a route whereby mV-22b
TMD stimulates phagocytosis independently of syntaxin 18 or D12. It is also possible that some modification such as focal regulation of NSF/
-SNAP (Zhao et al., 2007
) and/or phosphorylation of SNARE proteins might cause a structural change (Snyder et al., 2006
) to modify the availability of SNARE proteins.
|
SNARE complexes generally consist of a parallel helix bundle composed of four heptad repeat–containing SNARE motifs, three from Q-SNARE proteins and one from an R-SNARE protein (Jahn and Scheller, 2006
). Syntaxin 18 and D12 are Q-SNARE proteins involved in ER-mediated phagocytosis. However, Sec22b is apparently not a cognate R-SNARE protein because it inhibits syntaxin-mediated membrane fusion for phagocytosis as an i-SNARE (Varlamov et al., 2004
). Thus, the cognate R-SNARE protein that actively participates in this process remains unknown. A possible candidate is VAMP5, an R-SNARE protein localized to the plasma membrane (Zeng et al., 1998
), and/or Ykt6, an R-SNARE protein localized to both the cytosol and membrane (Figure 6). Ykt6 contains a palmitoylation site at its C-terminus and analyses using various mutants have indicated that some Ykt6 mutants are targeted to the plasma membrane (Fukasawa et al., 2004
; Hasegawa et al., 2004
). The cognate plasma membrane Q-SNARE(s) involved in this process also remains unidentified, although syntaxins 2–4 can interact with syntaxin 18 in vitro (Hatsuzawa et al., 2006
). Further studies are needed to elucidate the details of ER-mediated phagocytosis.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Address correspondence to: Kiyotaka Hatsuzawa (hatsu{at}fmu.ac.jp).
Abbreviations used: ECL, enhanced chemiluminescence; EGFP, enhanced green fluorescent protein; ER, endoplasmic reticulum; FITC, fluorescein isothiocyanate; i-SNARE, inhibitory SNARE; mVenus, monomeric Venus; SNAP-25, synaptosomal associated protein of 25 kDa; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor; TMD, transmembrane domain; VAMP, vesicle-associated membrane protein
| REFERENCES |
|---|
|
|
|---|
Ackerman, A. L., Kyritsis, C., Tampe, R., and Cresswell, P. (2003). Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad Sci. USA 100, 12889–12894.
Akagi, T., Sasai, K., and Hanafusa, H. (2003). Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc. Natl. Acad Sci. USA 100, 13567–13572.
Bajno, L., Peng, X. R., Schreiber, A. D., Moore, H. P., Trimble, W. S., and Grinstein, S. (2000). Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation. J. Cell Biol 149, 697–706.
Becker, T., Volchuk, A., and Rothman, J. E. (2005). Differential use of endoplasmic reticulum membrane for phagocytosis in J774 macrophages. Proc. Natl. Acad Sci. USA 102, 4022–4026.
Braun, V., Fraisier, V., Raposo, G., Hurbain, I., Sibarita, J. B., Chavrier, P., Galli, T., and Niedergang, F. (2004). TI-VAMP/VAMP7 is required for optimal phagocytosis of opsonised particles in macrophages. EMBO J 23, 4166–4176.[CrossRef][Medline]
Coppolino, M. G., Kong, C., Mohtashami, M., Schreiber, A. D., Brumell, J. H., Finlay, B. B., Grinstein, S., and Trimble, W. S. (2001). Requirement for N-ethylmaleimide-sensitive factor activity at different stages of bacterial invasion and phagocytosis. J. Biol. Chem 276, 4772–4780.
Czibener, C., Sherer, N. M., Becker, S. M., Pypaert, M., Hui, E., Chapman, E. R., Mothes, W., and Andrews, N. W. (2006). Ca2+ and synaptotagmin VII-dependent delivery of lysosomal membrane to nascent phagosomes. J. Cell Biol 174, 997–1007.
Desjardins, M. (2003). ER-mediated phagocytosis: a new membrane for new functions. Nat. Rev. Immunol 3, 280–291.[CrossRef][Medline]
Fasshauer, D., Sutton, R. B., Brunger, A. T., and Jahn, R. (1998). Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc. Natl. Acad Sci. USA 95, 15781–15786.
Fukasawa, M., Varlamov, O., Eng, W. S., Sollner, T. H., and Rothman, J. E. (2004). Localization and activity of the SNARE Ykt6 determined by its regulatory domain and palmitoylation. Proc. Natl. Acad Sci. USA 101, 4815–4820.
Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P. H., Steele-Mortimer, O., Paiement, J., Bergeron, J. J., and Desjardins, M. (2002). Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110, 119–131.[CrossRef][Medline]
Garin, J., Diez, R., Kieffer, S., Dermine, J. F., Duclos, S., Gagnon, E., Sadoul, R., Rondeau, C., and Desjardins, M. (2001). The phagosome proteome: insight into phagosome functions. J. Cell Biol 152, 165–180.
Groothuis, T. A., and Neefjes, J. (2005). The many roads to cross-presentation. J. Exp. Med 202, 1313–1318.
Guermonprez, P., Saveanu, L., Kleijmeer, M., Davoust, J., Van Endert, P., and Amigorena, S. (2003). ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425, 397–402.[CrossRef][Medline]
Haas, A. (2007). The phagosome: compartment with a license to kill. Traffic 8, 311–330.[CrossRef][Medline]
Hasegawa, H., Yang, Z., Oltedal, L., Davanger, S., and Hay, J. C. (2004). Intramolecular protein-protein and protein-lipid interactions control the conformation and subcellular targeting of neuronal Ykt6. J. Cell Sci 117, 4495–4508.
Hatsuzawa, K., Hirose, H., Tani, K., Yamamoto, A., Scheller, R. H., and Tagaya, M. (2000). Syntaxin 18, a SNAP receptor that functions in the endoplasmic reticulum, intermediate compartment, and cis-Golgi vesicle trafficking. J. Biol. Chem 275, 13713–13720.
Hatsuzawa, K., Tamura, T., Hashimoto, H., Yokoya, S., Miura, M., Nagaya, H., and Wada, I. (2006). Involvement of syntaxin 18, an endoplasmic reticulum (ER)-localized SNARE protein, in ER-mediated phagocytosis. Mol. Biol. Cell 17, 3964–3977.
Hay, J. C., Chao, D. S., Kuo, C. S., and Scheller, R. H. (1997). Protein interactions regulating vesicle transport between the endoplasmic reticulum and Golgi apparatus in mammalian cells. Cell 89, 149–158.[CrossRef][Medline]
Ho, Y. H., Cai, D. T., Wang, C. C., Huang, D., and Wong, S. H. (2008). Vesicle-associated membrane protein-8/endobrevin negatively regulates phagocytosis of bacteria in dendritic cells. J. Immunol 180, 3148–3157.
Houde, M., Bertholet, S., Gagnon, E., Brunet, S., Goyette, G., Laplante, A., Princiotta, M. F., Thibault, P., Sacks, D., and Desjardins, M. (2003). Phagosomes are competent organelles for antigen cross-presentation. Nature 425, 402–406.[CrossRef][Medline]
Jahn, R., Lang, T., and Sudhof, T. C. (2003). Membrane fusion. Cell 112, 519–533.[CrossRef][Medline]
Jahn, R., and Scheller, R. H. (2006). SNAREs—engines for membrane fusion. Nat. Rev. Mol. Cell. Biol 7, 631–643.[CrossRef][Medline]
Jutras, I., and Desjardins, M. (2005). Phagocytosis: at the crossroads of innate and adaptive immunity. Annu. Rev. Cell Dev. Biol 21, 511–527.[CrossRef][Medline]
Mancias, J. D., and Goldberg, J. (2007). The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope. Mol. Cell 26, 403–414.[CrossRef][Medline]
Muller-Taubenberger, A., Lupas, A. N., Li, H., Ecke, M., Simmeth, E., and Gerisch, G. (2001). Calreticulin and calnexin in the endoplasmic reticulum are important for phagocytosis. EMBO J 20, 6772–6782.[CrossRef][Medline]
Murray, R. Z., Kay, J. G., Sangermani, D. G., and Stow, J. L. (2005). A role for the phagosome in cytokine secretion. Science 310, 1492–1495.
Nakajima, K., Hirose, H., Taniguchi, M., Kurashina, H., Arasaki, K., Nagahama, M., Tani, K., Yamamoto, A., and Tagaya, M. (2004). Involvement of BNIP1 in apoptosis and endoplasmic reticulum membrane fusion. EMBO J 23, 3216–3226.[CrossRef][Medline]
Okumura, A. J., Hatsuzawa, K., Tamura, T., Nagaya, H., Saeki, K., Okumura, F., Nagao, K., Nishikawa, M., Yoshimura, A., and Wada, I. (2006). Involvement of a novel Q-SNARE, D12, in quality control of the endomembrane system. J. Biol. Chem 281, 4495–4506.
Paek, I., Orci, L., Ravazzola, M., Erdjument-Bromage, H., Amherdt, M., Tempst, P., Sollner, T. H., and Rothman, J. E. (1997). ERS-24, a mammalian v-SNARE implicated in vesicle traffic between the ER and the Golgi. J. Cell Biol 137, 1017–1028.
Pryor, P. R., Jackson, L., Gray, S. R., Edeling, M. A., Thompson, A., Sanderson, C. M., Evans, P. R., Owen, D. J., and Luzio, J. P. (2008). Molecular basis for the sorting of the SNARE VAMP7 into endocytic clathrin-coated vesicles by the ArfGAP Hrb. Cell 134, 817–827.[CrossRef][Medline]
Snyder, D. A., Kelly, M. L., and Woodbury, D. J. (2006). SNARE complex regulation by phosphorylation. Cell Biochem. Biophys 45, 111–123.[CrossRef][Medline]
Touret, N. et al. (2005). Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123, 157–170.[CrossRef][Medline]
Varlamov, O. et al. (2004). i-SNAREs: inhibitory SNAREs that fine-tune the specificity of membrane fusion. J. Cell Biol 164, 79–88.
Vinet, A. F., Fukuda, M., and Descoteaux, A. (2008). The exocytosis regulator synaptotagmin V controls phagocytosis in macrophages. J. Immunol 181, 5289–5295.
Zeng, Q., Subramaniam, V. N., Wong, S. H., Tang, B. L., Parton, R. G., Rea, S., James, D. E., and Hong, W. (1998). A novel synaptobrevin/VAMP homologous protein (VAMP5) is increased during in vitro myogenesis and present in the plasma membrane. Mol. Biol. Cell 9, 2423–2437.
Zhao, C., Slevin, J. T., and Whiteheart, S. W. (2007). Cellular functions of NSF: not just SNAPs and SNAREs. FEBS Lett 581, 2140–2149.[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||